Related Experiment Videos

Mucin-producing pancreatic tumors: a study of nuclear DNA content by flow cytometry

Y Murakami1, T Yokoyama, T Kodama

  • 1First Department of Surgery, Hiroshima University School of Medicine, Japan.

Surgery Today
|January 1, 1993
PubMed

Insights

Nuclear DNA content analysis in mucin-producing pancreatic tumors (MPPT) revealed that most tumors were DNA diploid, suggesting a favorable prognosis. A DNA aneuploid tumor was observed in one advanced case.

Area of Science:

  • Oncology
  • Pathology
  • Genetics

Background:

  • Mucin-producing pancreatic tumors (MPPT) encompass a spectrum of neoplastic lesions.
  • Accurate prognostic markers for MPPT are crucial for clinical management.

Purpose of the Study:

  • To investigate the correlation between nuclear DNA content and clinicopathological features in MPPT.
  • To assess the prognostic value of DNA ploidy in MPPT.

Main Methods:

  • Flow cytometry was employed to measure nuclear DNA content in paraffin-embedded MPPT samples.
  • Tissue preparation involved single nucleus dissociation (Shutte technique) and propidium iodide staining (Vindelov method).

Main Results:

  • Seven of eight MPPT cases exhibited DNA diploid tumors.
  • One mucinous intraductal adenocarcinoma (MIDAC) with duodenal and choledochal perforation showed DNA aneuploidy.
  • Clinicopathological differences were noted between tumor subtypes and locations, with gender and pancreatic region variations observed.

Conclusions:

  • DNA diploidy in MPPT appears associated with a favorable prognosis.
  • DNA aneuploidy may occur in MPPT with extensive local invasion.

Related Concept Videos